Device Trial Radar · NCT05135403
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Last checked: Nov 20, 2026Latest source record: Sep 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5,179
Planned (sponsor's estimate)
Start
Nov 20, 2021
Primary completion
Oct 1, 2025
Study completion Oct 1, 2025
Sponsor
- Lead sponsor
- Kestra Medical Technologies, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 26, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.
Conditions
- Sudden Cardiac Arrest
Interventions
DefibrillationDevice
External defibrillation from a wearable cardioverter defibrillator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall shock conversion rateTime frame: Up to 3 years
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Washington Medical Center
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.